Mystic Holdings Valuation
Is MSTH undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 4/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MSTH?
Other financial metrics that can be useful for relative valuation.
|What is MSTH's n/a Ratio?|
Price to Sales Ratio vs Peers
How does MSTH's PS Ratio compare to its peers?
|Company||PS||Estimated Growth||Market Cap|
ENDP.Q Endo International
RDHL RedHill Biopharma
MSTH Mystic Holdings
Price to Earnings Ratio vs Industry
How does MSTH's PE Ratio compare vs other companies in the US Pharmaceuticals Industry?
Price to Sales Ratio vs Fair Ratio
What is MSTH's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||1.5x|
|Fair PS Ratio||n/a|
Price-To-Sales vs Fair Ratio: Insufficient data to calculate MSTH's Price-To-Sales Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of MSTH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?